About two months after former Spectranetics CEO Scott Drake became executive board chair at Cordis, he's moved into the corner office at the cardiology and endovascular devices company. Drake replaces Shar Matin, who has stepped down as CEO, the company announced yesterday. Hunter Philbrick, Hellman & Friedman partner and company board … [Read more...] about Cordis has a new CEO
Cordis
Cordis applauds Medicare expansion for carotid stenting
Cordis announced today that it supports a new expanded coverage decision from the Centers for Medicare & Medicaid Services (CMS). The expanded CMS coverage widens access to minimally invasive endovascular carotid therapy for patients with carotid artery disease. Cordis develops the Precise Pro Rx carotid stent system for this therapy. In a … [Read more...] about Cordis applauds Medicare expansion for carotid stenting
Cordis acquires drug-eluting balloon maker MedAlliance for up to $1.135B
MedAlliance announced today that Cordis acquired it for a total consideration that could reach up to $1.135 billion. The companies initially announced the planned deal in October of last year. Cordis, which develops interventional cardiovascular and endovascular technologies, made a $35 million investment last year. Its upfront closing … [Read more...] about Cordis acquires drug-eluting balloon maker MedAlliance for up to $1.135B
Cordis among those investing $15M in Endovascular Engineering
Endovascular Engineering today announced the closing of a $15 million Series A1 financing co-led by Santé Ventures and Cordis. The Menlo Park, California–based startup is also called E2. It's focused on developing advanced mechanical thrombectomy technology. "With the close of this funding, we will continue the journey from concept to … [Read more...] about Cordis among those investing $15M in Endovascular Engineering
Cordis names new CFO
Cordis today announced that it has appointed Christopher Scully as chief financial officer. Scully will be responsible for leading the interventional cardiovascular technology company’s financial and IT functions to accelerate Cordis’s growth. Prior to joining the company, Scully was executive VP and CFO for PPD. Get the full story on our … [Read more...] about Cordis names new CFO
Cordis recalls some Smart Flex vascular stent systems
Cordis recently issued a warning letter regarding an issue with its Smart Flex vascular stent system. Santa Clara, California-based Cordis's field safety correction action informs users that some of its Smart Flex vascular stents have the potential for distal tip dislodgment or separation due to inadequate adhesive application. The recall … [Read more...] about Cordis recalls some Smart Flex vascular stent systems
FDA says Cordis carotid artery stent recall is serious
The FDA has classified Cordis‘ recall of its Precise Pro Rx carotid system as Class I, the most serious kind of recall. Cordis in February recalled certain lots of its Precise Pro RX carotid stent systems because of a risk of separation of the atraumatic distal tip of the sheathed delivery system in patients. Get the full story at our sister … [Read more...] about FDA says Cordis carotid artery stent recall is serious
